Home » Authors » Anette Breindl

Articles by Anette Breindl

One-Kind-Makes-All Could Be Path To Development Of Heart

Nov. 28, 2006

By Anette Breindl

One-Kind-Makes-All Could Be Path To Development Of Heart

Nov. 28, 2006

By Anette Breindl

Methods Predict How Proteins, Nucleic Acids Get Into Shape

Nov. 22, 2006

By Anette Breindl

Methods Predict How Proteins, Nucleic Acids Get Into Shape

Nov. 22, 2006

By Anette Breindl

At ACR 2006, New Avenues For Building Better Wolftrap

Nov. 21, 2006

By Anette Breindl

At ACR 2006, New Avenues For Building Better Wolftrap

Nov. 21, 2006

By Anette Breindl

Alzheimer's Drug Development Target Has Role In Myelination

Nov. 17, 2006

By Anette Breindl

Alzheimer's Drug Development Target Has Role In Myelination

Nov. 17, 2006

By Anette Breindl

Research in Gene Expression Leads To Findings In Epilepsy

Nov. 14, 2006

By Anette Breindl

Research in Gene Expression Leads To Findings In Epilepsy

Nov. 14, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...